A collection of news and information related to Genentech Inc. published by this site and its partners.
Displaying items 1-12 of 63 » View latimes.com items only1 2 3 4 5 6 Next >
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...
When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...
In another major setback for efforts to develop an HIV vaccine, federal researchers have shut down a key clinical trial after an independent panel of safety experts determined that volunteers who got an experimental vaccine appeared to be slightly more...
WASHINGTON — President Obama's second inaugural committee raised a little more than $43 million to put on the official festivities surrounding his January swearing-in, backed by major donations from some of the country's biggest corporations,...
Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...
One of the most promising frontiers in healthcare is biologic medicines — complex substances derived from living cells that can help fight chronic diseases and cancers. To encourage investment in biologics, Congress in 2010 gave drug companies...
SAN FRANCISCO -- Facebook is rolling out a radical new redesign of News Feed, the biggest since it launched the feature in 2006. The giant social network plans to unveil the redesign at a press conference Thursday at its Menlo Park, Calif.,...
WASHINGTON — With less than a week to go before President Obama is sworn in for his second term, fundraisers for the presidential inaugural committee were still working Monday to secure their goal of $50 million in private donations to finance the...
In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The...
Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members. Roche’s current offer of $51 per Illumina...
TechnologyIn the first change to Apple's boardroom since the death of Steve Jobs last month, the company announced that Walt Disney Co. President and Chief Executive Robert Iger will be the Cupertino electronics maker's newest board member....
Opinion L.A.Avastin: The FDA goes up against drug manufacturer Genentech with regards to the late-stage cancer drug....
May 12, 2013 |Story| Los Angeles Times
Apr 19, 2013 |Story| Los Angeles Times
Apr 25, 2013 |Story| Los Angeles Times
Apr 22, 2013 |Story| Los Angeles Times
Mar 29, 2013 |Story| Los Angeles Times
Mar 17, 2013 |Story| Los Angeles Times
Mar 6, 2013 |Story| Los Angeles Times
Jan 14, 2013 |Story| Los Angeles Times
Jan 30, 2012 |Story| Los Angeles Times
Apr 18, 2012 |Story| Los Angeles Times
Nov 15, 2011 | Los Angeles Times
Jun 28, 2011 | Los Angeles Times
Original site for Genentech Inc. topic gallery.